Autopsy report · NCT02922725

Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females

“COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 6 months before it stopped.
• 32 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Brent Michael Kious, MD, PhD

Sponsor type

University, hospital or other

Conditions

Major Depressive Disorder

Interventions

5-hydroxytryptophan and Creatine; Placebo control

Participants

32

Sites

1

Countries

United States

Trials that died the same way

• Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
  “COVID pandemic” (90% match in meaning)
• Dry Needling for Patients With Back Pain
  “COVID-19” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.